Xcout Intel
Qnomx
Headquartered in Basel, Switzerland, Qnomx was founded in 2022 to provide an AI-native platform for clinical genomic interpretation. The platform is designed to assist genomicists by automating the manual process of gathering evidence for genetic variants.
Subscribe to see Qnomx’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Qnomx at a glance
Qnomx is a healthtech company headquartered in Switzerland. Its most recent funding round, Pre-Seed, raised $2M in April 2025. Xcout tracks 6 named people at Qnomx, including James Creeden (Co-CEO).
Qnomx leadership
- James CreedenCo-CEO
- Joerg HoelzingCo-CEO
- Marcus OlivecronaCTO
- James CreedenCo-Founder & Co-CEO
- Joerg HoelzingCo-Founder & Co-CEO
- Marcus OlivecronaCo-Founder & CTO
Qnomx funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $2M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Qnomx competitors
A few of Qnomx's closest competitors — see the full list of competitors and alternatives →
Quantum Life Enterprises develops an AI-powered multi-omics platform designed for longevity medicine and precision healthcare. The platform provides clinics, laboratories, and healthcare providers with clinical-grade insights and assessments to support proactive care and personalized longevity interventions.
Indivi AG is a biotechnology research company headquartered in Basel, Switzerland. It focuses on pioneering the future of precision neurology through digital biomarkers for clinical research and patient monitoring, dedicated to unlocking the potential of digital measurements in drug development.
Probably Genetic is a healthcare technology company focused on helping identify rare genetic diseases through genetic testing and clinical software. It serves patients with undiagnosed conditions and the healthcare professionals involved in their diagnosis and care.
Igentify is a digital health company headquartered in Caesarea, Israel. It has developed a true end-to-end solution for genetic services, aiming to provide effective solutions in this field.
gMendel is a medical technology company founded in 2020 that develops an AI-powered, cloud-based platform combining genomics with artificial intelligence. The company provides decision support software designed to enable faster, more accurate, and scalable diagnosis of genetic disorders.
SeqOne Genomics is a certified medical device and technology company providing a smart genomics platform that leverages artificial intelligence to support genomic data analysis.
Get Qnomx's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Qnomx in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access